News Archives:20262025202420232022202120202019
June 17, 2026
IBN Marks Its 20th Anniversary with a Reflection on 2 Decades of Growth, Innovation and the Road Ahead as IBN.Ai
Looking ahead to the next chapter with IBN.Ai, an AI-driven evolution designed to enhance investor intelligence, business intelligence and strategic communications capabilities.
June 2, 2026
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
To begin the interview, Durkacz outlined Quantum BioPharma’s primary focus on advancing its lead multiple sclerosis drug candidate, Lucid-MS.
May 20, 2026
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc.
To begin the interview, Dr. Dogan outlined Cardio Diagnostics’ mission to improve the prevention and early detection of cardiovascular disease through precision medicine.
May 19, 2026
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Robert Price, CEO of Greenland Energy Company
To begin the interview, Price discussed Greenland Energy’s recent financing and its fully funded drilling program in the Jameson Land Basin.
May 12, 2026
IBN Announces Latest Episode of The TechMediaWire Podcast featuring Justin Hanka, CEO of MindBio Therapeutics Corp.
To begin the interview, Hanka described MindBio’s work using voice as a biomarker to detect drug and alcohol intoxication through non-invasive AI-driven analysis.
April 30, 2026
IBN Announces Latest Episode of The TechMediaWire Podcast featuring Etienne Moshevich, CEO of Planet Ventures Inc.
To begin the interview, Moshevich outlined Planet Ventures’ transformation over the past two and a half years.
April 21, 2026
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Gordon Robb, CEO of ESGold Corp.
To begin the interview, Robb described ESGold as a differentiated story within the junior mining sector, centered on near-term production and internally funded growth at its Montauban Gold-Silver Project in Quebec.
April 14, 2026
IBN Supercharges Global Investor Reach for The Market Link via InvestorWire
The collaboration reflects a shared commitment to delivering targeted, high-impact communications that resonate across diverse investor audiences.
April 8, 2026
IBN Initiates Coverage of Cardio Diagnostics Holdings Inc.
Cardio Diagnostics develops and commercializes blood-based clinical tests and data solutions designed to support the prevention, detection, and management of cardiovascular disease.
April 7, 2026
IBN Initiates Coverage of Versus Systems Inc.
Versus Systems is a technology company focused on enhancing how audiences interact with content across digital and live environments.
March 24, 2026
IBN Announces Latest Episode of The GotStocks Podcast featuring Matthew McKean, CEO of Frontieras North America Inc.
To begin the interview, McKean outlined the company’s origins and mission to modernize coal utilization through its patented FASForm™ technology.
March 19, 2026
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
To begin the interview, Dr. Schaber addressed the upcoming interim analysis of the company’s Phase 3 FLASH2 study evaluating HyBryte™.
March 10, 2026
IBN Announces Latest Episode of The Stock2Me Podcast featuring Brent Nelson, CEO of Kepler Fusion Technologies, a Renewal Fuels Inc. Subsidiary
To begin the interview, Nelson addressed the company’s ambitious timeline to deliver a fully operational 100-megawatt fusion reactor.
March 5, 2026
IBN Announces Latest Episode of The TechMediaWire Podcast featuring Marshall Chapin, CEO of Grid AI Corp.
To begin the interview, Chapin provided an overview of GridAI’s core mission and the infrastructure challenges the company aims to address within the accelerating AI buildout.
February 25, 2026
IBN Initiates Coverage of Frontieras North America Inc.
Frontieras is developing its first commercial-scale facility in West Virginia, designed to process approximately 7,500 tons of coal per day, or about 2.7 million tons annually.
February 24, 2026
IBN Announces Latest Episode of The TechMediaWire Podcast featuring David BenDavid, CEO of Rail Vision Ltd.
To begin the interview, BenDavid provided an overview of Rail Vision’s core mission and the value its technology is designed to deliver to rail operators worldwide.
February 17, 2026
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Giorgio R. Saumat, CEO of Earth Science Tech Inc.
To begin the interview, Saumat outlined Earth Science Tech’s core business model and how the company has structured its healthcare operations.
February 11, 2026
IBN Initiates Coverage of Renewal Fuels Inc., Operating as American Fusion
American Fusion has repositioned its operations around the development and long-term commercialization of deployable fusion power systems.
January 26, 2026
IBN Initiates Coverage of GridAI Technologies Corp.
Following its acquisition of Grid AI Corp., GridAI Technologies is focused on enabling more flexible, resilient, and economically optimized electricity systems.
January 23, 2026
IBN Initiates Coverage of Earth Science Tech Inc.
Earth Science Tech is focused on advancing a portfolio of operating businesses within regulated healthcare markets, emphasizing execution, compliance, and disciplined scaling.
January 15, 2026
IBN Initiates Coverage of Rail Vision Ltd.
Rail Vision develops rail-specific detection systems designed to improve visibility, hazard detection, and situational awareness across railway networks.
January 14, 2026
IBN Initiates Coverage of ParaZero Technologies Ltd.
ParaZero specializes in multi-layered Counter-Unmanned Aircraft System (“Counter-UAS”) technologies designed to neutralize hostile drones in complex, contested, and urban environments.
January 13, 2026
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
LIXTE Biotechnology is a clinical-stage pharmaceutical company developing differentiated cancer therapies built around a novel biological target designed to enhance the effectiveness of existing cancer treatments.